Los puntos clave no están disponibles para este artículo en este momento.
This study evaluates the cost of routine pretreatment electrocardiogram screening and determines whether testing led to significant management changes for 198 patients evaluated for initiation of treatment with propranolol over a 2-year period.
Streicher et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: